New drug combo after stroke shows promise in preventing early decline
NCT ID NCT07295366
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after a stroke procedure (thrombectomy) could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard care or standard care alone. The main goal was to see if the drug reduced the chance of early decline or death within a week.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL ATHEROSCLEROTIC LARGE VESSEL OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- A Pocket-Sized MRI for strokes? new device put to the test
- Does a dedicated stroke unit boost recovery after a first stroke?
- Could inflammation after stroke trigger depression?
- Pocket-Sized MRI could spot strokes at bedside
- Could common drugs curb brain bleed aftermath?